By proceeding, you agree to our Terms of Use and Privacy Policy.
Tazin Aijaz is curently working as Clinical and Scientific Director - Nephrology/Rare Disease at Otsuka Pharmaceutical Companies (U.S.).
Talks About #neurology
Preferred Locations #Northamerica
The surge of clinical approvals in CKD and unprecedented use of surrogate endpoints in rare kidney diseases have catalysed a new era of complimentary therapies and precision medicine in drug development for kidney disease.